Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How transparent were the COVID vaccine trials?

Daniel Hopkins, MD
Conditions
January 10, 2021
187 Shares
Share
Tweet
Share

On March 2nd, 2020, as New York State announced its first proven case of COVID-19, a federal court there handed down a stunning decision. For 10 years, according to the court, the United States government illegally failed to hold drug companies accountable when they did not report, or inaccurately reported, crucial data about their drugs’ safety and efficacy.

Between 2007 and 2017, the court held, the Food and Drug Administration knew of instances from roughly 1,000 drug trials in which manufacturers hid or misrepresented data. According to legislation passed in 1997, the FDA must publicly report such breaches. But to this day, they have not.

One week later, Donald Trump announced COVID-19 was “very much under control,” safer than the flu, and cases would soon be zero. We learned that the government would shrug its shoulders just as brazenly with COVID-19 as it had with drug company deceit. The federal government would become a stone-faced observer for the country’s most dire national disaster in a century, a failure that quickly eclipsed perhaps the most important legal decision on public health in a century. But it all comes full circle, eventually.

Millions of lives now depend on companies’ transparency that have spent decades hiding and distorting their scientific data. Pfizer, Moderna, AstraZeneca, and other drugmakers were put in charge of the best short-term option the world has for stanching the flow from a biblical pestilence that has killed hundreds of thousands of Americans and millions more globally (so far).

In public statements more befitting an SNL cold open, or perhaps an Onion headline, the drug companies have repeatedly promised to be transparent and ethical in developing, testing, and distributing COVID vaccines. But these are not just old dogs claiming to learn a new trick. These are morbidly obese, henhouse foxes with a Cheshire grin and a golden toothpick in their teeth.

Dr. Peter Doshi, a health services researcher and editor at the British Medical Journal, is familiar with that grin. Doshi examined hundreds of thousands of pages of study reports dumped on his head by spiteful drug companies forced into “transparency” by public outrage when it was discovered they hid and misrepresented data on Tamiflu years ago. The pricey blockbuster drug, stockpiled by governments as a bioterrorism remedy and commonly used worldwide as a “cure” for the flu, is no better than a dose of ibuprofen at the local pharmacy. This we learned from Doshi, Tom Jefferson, and others who gave years of their lives sifting through the data.

Now, Doshi, a default transparency watchdog for the drug industry, has published what amounts to a transparency challenge for Pfizer, Moderna, and other vaccine makers. After reviewing published data this week, he reports on a number of gaping holes in the vaccine data, holes that need to be filled if the company claims their vaccines are considered credible.

Most prominent and most concerning, is the absence of data first reported weeks ago by editors at TheNNT.com, an open access, physician-run website for health care evidence reviews. Doshi confirms: FDA documents show in Pfizer’s vaccine trial thousands of patients experienced “suspected but unconfirmed” COVID-19, with no mention of who was tested, or how many. Were suspected cases all tested, as the study protocol calls for? Were they tested equally in vaccine and placebo groups? With just 170 cases of COVID-19 reported in the trial, but more than 3000 suspected cases, any imbalance in testing between groups could easily affect—or even reverse—the trial’s results.

Doshi also points to 371 study subjects mysteriously “excluded” from Pfizer’s analysis and the potential effects of unblinding caused by vaccine injection side effects. His points are valid and crucial, each representing potentially game-changing results from the trial—and each could be resolved with access to the raw trial data.

So how about it, Pfizer? And Moderna? Is genuine transparency something you can do? In the modern world’s moment of greatest humanitarian crisis, can you open the books? Or have decades of hiding and distorting hardened you? Can you show us you’re willing to play fair?

If only we had a government of the people, instead of above the people. This would be a snap.

Daniel Hopkins is a physician.

Image credit: Shutterstock.com 

Prev

When an epidemic of violence against health care workers meets a pandemic [PODCAST]

January 9, 2021 Kevin 0
…
Next

Why do I laugh during a pandemic?

January 10, 2021 Kevin 3
…

Tagged as: COVID, Infectious Disease

Post navigation

< Previous Post
When an epidemic of violence against health care workers meets a pandemic [PODCAST]
Next Post >
Why do I laugh during a pandemic?

More by Daniel Hopkins, MD

  • A physician questions the COVID vaccine data from Israel

    Daniel Hopkins, MD
  • Enthusiasm over evidence? What the Israeli vaccination data actually show.

    Daniel Hopkins, MD
  • Why remdesivir may not be a wonder drug

    Daniel Hopkins, MD

Related Posts

  • Major medical groups back mandatory COVID vaccine for health care workers

    Molly Walker
  • Is it time for a true federal COVID vaccine mandate?

    Shetal Shah, MD
  • The COVID vaccine selfie: The caption matters as much as the picture

    Alicia Billington, MD, PhD
  • COVID-19 divides and conquers

    Michele Luckenbaugh
  • Where’s the big COVID data?

    Anuradha Kolluru, MD and Rakesh Lattupalli, MD
  • COVID-19 vaccine and disinformation: How health care providers can leverage social media to combat this trend

    Emmanuel Ohuabunwa, MD, MBA, Victor Agbafe, and Onyema Ogbuagu, MD

More in Conditions

  • The beauty of a patient’s gratitude

    Dr. Damane Zehra
  • From clocking in to clocking out: the transition to retirement

    Debbie Moore-Black, RN
  • Overcoming Parkinson’s: a journey of laughter and resilience

    Cynthia Poire Mathews, FNP
  • The untold struggles patients face with resident doctors

    Denise Reich
  • Maximize sleep efficiency with stimulus control

    Pedram Navab, DO
  • The endless waves of chronic illness

    Michele Luckenbaugh
  • Most Popular

  • Past Week

    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • Beyond pizza and pens: National Doctors’ Day should be about saving lives

      James Young, MD | Physician
    • Physicians are a finite resource we need to protect

      Jack Resneck, Jr., MD | Physician
    • From clocking in to clocking out: the transition to retirement

      Debbie Moore-Black, RN | Conditions
    • Unlearning our habits: a journey from intelligence to wisdom

      Brian Sayers, MD | Physician
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
  • Recent Posts

    • Unlearning our habits: a journey from intelligence to wisdom

      Brian Sayers, MD | Physician
    • Lessons from an orthopedic surgery journey [PODCAST]

      The Podcast by KevinMD | Podcast
    • Beyond pizza and pens: National Doctors’ Day should be about saving lives

      James Young, MD | Physician
    • Maximizing physician potential: How coaching can aid in conflict resolution, enhance health care leadership and build stronger teams

      Asha Padmanabhan, MD | Physician
    • The future of education: AI empowerment, YouTube college credits, and the impact on traditional colleges

      Harvey Castro, MD, MBA | Tech
    • The beauty of a patient’s gratitude

      Dr. Damane Zehra | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Moderna's Steep COVID Vaccine Price: Corporate Greed or Capitalism?
  • House Republican Argues Against FDA Budget Increase
  • Prescriptions for Stimulants Jumped During the Pandemic
  • Federal Judge Strikes Down ACA's Preventive Care Coverage Requirements
  • Pandemic Jump in ED Visits for Firearm Injuries Continued Into 2022

Meeting Coverage

  • VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapy
  • Obesity's Impact on Uterine Cancer Risk Greater in Younger Age Groups
  • Oral Roflumilast Effective in the Treatment of Plaque Psoriasis
  • Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer
  • Cannabis Use Common in Post-Surgery Patients on Opioid Tapering
  • Most Popular

  • Past Week

    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • The untold struggles patients face with resident doctors

      Denise Reich | Conditions
    • Beyond pizza and pens: National Doctors’ Day should be about saving lives

      James Young, MD | Physician
    • Physicians are a finite resource we need to protect

      Jack Resneck, Jr., MD | Physician
    • From clocking in to clocking out: the transition to retirement

      Debbie Moore-Black, RN | Conditions
    • Unlearning our habits: a journey from intelligence to wisdom

      Brian Sayers, MD | Physician
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
  • Recent Posts

    • Unlearning our habits: a journey from intelligence to wisdom

      Brian Sayers, MD | Physician
    • Lessons from an orthopedic surgery journey [PODCAST]

      The Podcast by KevinMD | Podcast
    • Beyond pizza and pens: National Doctors’ Day should be about saving lives

      James Young, MD | Physician
    • Maximizing physician potential: How coaching can aid in conflict resolution, enhance health care leadership and build stronger teams

      Asha Padmanabhan, MD | Physician
    • The future of education: AI empowerment, YouTube college credits, and the impact on traditional colleges

      Harvey Castro, MD, MBA | Tech
    • The beauty of a patient’s gratitude

      Dr. Damane Zehra | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

How transparent were the COVID vaccine trials?
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...